Related Experiment Video
Updated: Jun 6, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Progressive multifocal leukoencephalopathy and other forms of JC virus disease
Bruce J Brew1, Nicholas W S Davies, Paola Cinque
1Department of Neurology and St Vincent's Center for Applied Medical Research, St Vincent's Hospital and University of New South Wales, Victoria Street, Sydney, NSW 2010, Australia. b.brew@unsw.edu.au
Abstract:
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain caused by the JC virus (JCV). PML usually occurs via reactivation of JCV when an immune system becomes compromised. A diagnosis of PML is normally made on the basis of distinguishing neurological features at presentation, characteristic brain MRI changes and the presence of JCV DNA in cerebrospinal fluid. PML has a 3 month mortality rate of 20-50%, so prompt intervention is essential. Currently, reconstitution of the immune system affords the best prognosis for this condition. When PML is first suspected, and where possible, immunosuppressant or immunomodulatory therapy should be suspended or reduced. If PML is associated with a protein therapy that has a long half-life the use of plasma exchange to accelerate the removal of the drug from the circulation may aid the restoration of immune system function. Rapid improvements in immune function, however, might lead to transient worsening of the disease. In this Review, we critically appraise the controversies surrounding JCV infection, and provide practical management guidelines for PML.
Insights
Progressive multifocal leukoencephalopathy (PML), a brain disease caused by JC virus (JCV), requires prompt intervention. Reconstituting the immune system is key for managing PML and improving patient prognosis.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating brain disease.
- PML is caused by the JC virus (JCV) and typically occurs in immunocompromised individuals.
- High mortality rates (20-50% within 3 months) necessitate urgent management.
Purpose of the Study:
- To critically review controversies surrounding JCV infection.
- To provide practical management guidelines for PML.
- To highlight the importance of prompt intervention in PML cases.
Main Methods:
- Review of existing literature on PML and JCV infection.
- Analysis of diagnostic criteria including neurological presentation, MRI, and CSF JCV DNA.
- Discussion of therapeutic strategies focusing on immune reconstitution.
Main Results:
- Diagnosis relies on clinical, radiological, and laboratory findings.
- Immune system reconstitution is the primary treatment strategy.
- Suspension or reduction of immunosuppressive therapy is crucial.
- Plasma exchange may be considered for long half-life therapies.
Conclusions:
- Prompt diagnosis and intervention are essential for PML management.
- Restoring immune function offers the best prognosis.
- Careful management is needed to balance immune recovery and potential disease worsening.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Arboviral Encephalitis
Cytomegalovirus Disease
Cryptococcal Meningitis
Cerebral Edema ll: Pathophysiology

